Compare IPSC & HLLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IPSC | HLLY |
|---|---|---|
| Founded | 2019 | 1903 |
| Country | United States | United States |
| Employees | 78 | 1483 |
| Industry | Medicinal Chemicals and Botanical Products | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 407.6M | 395.5M |
| IPO Year | 2021 | N/A |
| Metric | IPSC | HLLY |
|---|---|---|
| Price | $2.27 | $2.55 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 6 |
| Target Price | $4.25 | ★ $4.83 |
| AVG Volume (30 Days) | 644.7K | ★ 762.2K |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 91.30 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $109,164,000.00 | N/A |
| Revenue This Year | N/A | $6.32 |
| Revenue Next Year | N/A | $4.98 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1556.76 | N/A |
| 52 Week Low | $0.44 | $1.91 |
| 52 Week High | $2.97 | $4.48 |
| Indicator | IPSC | HLLY |
|---|---|---|
| Relative Strength Index (RSI) | 49.15 | 38.25 |
| Support Level | $2.15 | N/A |
| Resistance Level | $2.41 | $4.35 |
| Average True Range (ATR) | 0.13 | 0.18 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 56.67 | 15.93 |
Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, meaning it is derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. The cell types it can generate from iPSCs, including iPSC-derived beta islet cells, iPSC-derived CD4+ and CD8+ alphabeta T cells, or alphabeta iT cells, and iPSC- natural killer cells, or iNK cells.
Holley Inc designs, manufactures, and distributes high-performance automotive aftermarket products to car and truck enthusiasts in the United States, Canada and Europe. It manufactures a diversified line of performance automotive products, including carburetors, fuel pumps, fuel injection systems, nitrous oxide injection systems, superchargers, exhaust headers, mufflers, distributors, ignition components, engine tuners and automotive performance plumbing products. It also manufactures exhaust products as well as shifters, converters, transmission kits, transmissions, tuners and automotive software. The company markets its products under brands such as Holley, Holley EFI, MSD, Simpson, Flowmaster, EDGE, Cataclean, and Accel, among others. It operates in single segment.